Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Roksana Sadeghi"'
Autor:
Roksana Sadeghi, Arathy Kartha, Michael P. Barry, Paul Gibson, Avi Caspi, Arup Roy, Duane R. Geruschat, Gislin Dagnelie
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Visual prostheses such as the Argus II provide partial vision for individuals with limited or no light perception. However, their effectiveness in daily life situations is limited by scene complexity and variability. We investigated whether
Externí odkaz:
https://doaj.org/article/068ee74c5e184a9c85b3ef72d7409da1
Autor:
Arathy Kartha, Roksana Sadeghi, Chris Bradley, Brittnee Livingston, Chau Tran, Will Gee, Gislin Dagnelie
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
IntroductionUltra low vision (ULV) refers to profound visual impairment where an individual cannot read even the top line of letters on an ETDRS chart from a distance of 0.5 m. There are limited tools available to assess visual ability in ULV. The ai
Externí odkaz:
https://doaj.org/article/2a46daa15cc74e1c8b37fbc733e600e4
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract People with ULV (visual acuity ≤ 20/1600 or 1.9 logMAR) lack form vision but have rudimentary levels of vision that can be used for a range of activities in daily life. However, current clinical tests are designed to assess form vision and
Externí odkaz:
https://doaj.org/article/234d9823a5784fd7bb73691192b84884
Autor:
Ezgi I. Yücel, Roksana Sadeghi, Arathy Kartha, Sandra Rocio Montezuma, Gislin Dagnelie, Ariel Rokem, Geoffrey M. Boynton, Ione Fine, Michael Beyeler
Publikováno v:
Frontiers in Neuroscience, Vol 16 (2022)
Two of the main obstacles to the development of epiretinal prosthesis technology are electrodes that require current amplitudes above safety limits to reliably elicit percepts, and a failure to consistently elicit pattern vision. Here, we explored th
Externí odkaz:
https://doaj.org/article/11885c96f8cb4bec8d432beb36430450
Autor:
Fariba Farnaghi, Haleh Talaie, Zahra Pournasiri, Roksana Sadeghi, Hamid Owliaey, Hossein Hassanian-Moghaddam, Shahin Shadnia
Publikováno v:
Iranian Journal of Toxicology, Vol 6, Iss 19, Pp 746-750 (2013)
Background: Acute intoxication with ALP is extremely lethal. The present study was conducted to determine the range of serum cortisol levels in ALP poisoning and its correlation with patient outcome. Methods: This study was carried out on patients w
Externí odkaz:
https://doaj.org/article/d9535018550849b29c6efd259fb03a23
Autor:
Breanne Christie, Roksana Sadeghi, Arathy Kartha, Chigozie Ewulum, Avi Caspi, Francesco V. Tenore, Roberta L. Klatzky, Gislin Dagnelie, Seth Billings
Publikováno v:
2023 11th International IEEE/EMBS Conference on Neural Engineering (NER).
Autor:
Breanne Christie, Roksana Sadeghi, Arathy Kartha, Avi Caspi, Francesco V. Tenore, Roberta L. Klatzky, Gislin Dagnelie, Seth Billings
Publikováno v:
J Neural Eng
ObjectiveElectrical stimulation of the retina can elicit flashes of light called phosphenes, which can be used to restore rudimentary vision for people with blindness. Functional sight requires stimulation of multiple electrodes to create patterned v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a49af226c8ead606e780863b4c76ca9
https://doi.org/10.1101/2022.03.08.22270800
https://doi.org/10.1101/2022.03.08.22270800
Autor:
Ezgi Yucel, Michael Beyeler, Roksana Sadeghi, Arathy Kartha, Gislin Dagnelie, Ariel Rokem, Ione Fine
Publikováno v:
Journal of Vision. 22:3754
Publikováno v:
EMBC
Tracking the eye of a blind patient can enhance the usability of an artificial vision system. In systems where the sensing element, i.e. the scene camera that captures the visual information, is mounted on the patient's head, the user must use head s
Autor:
Arup Roy, Avi Caspi, Paul Gibson, Chris Bradley, Arathy Kartha, Michael P. Barry, Roksana Sadeghi, Gislin Dagnelie
Publikováno v:
Vision Res
To date, retinal implants are the only available treatment for blind individuals with retinal degenerations such as retinitis pigmentosa. Argus II is the only visual implant with FDA approval, with more than 300 users worldwide. Argus II stimulation